# Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects

> **NCT03802786** · PHASE1 · COMPLETED · sponsor: **Poxel SA** · enrollment: 14 (actual)

## Conditions studied

- Hepatic Impairment

## Interventions

- **DRUG:** Imeglimin

## Key facts

- **NCT ID:** NCT03802786
- **Lead sponsor:** Poxel SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-06
- **Primary completion:** 2019-07-03
- **Final completion:** 2019-07-08
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2020-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03802786

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03802786, "Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03802786. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*